Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1681 USD | +1.51% | +4.60% | -85.02% |
May. 14 | Wall Street Set to Open Flat Tuesday as Key Inflation Gauge Rises More Than Expected | MT |
May. 14 | Top Premarket Decliners | MT |
Financials (USD)
Sales 2024 * | 50.67M | Sales 2025 * | 54.66M | Capitalization | 5.53M |
---|---|---|---|---|---|
Net income 2024 * | -10M | Net income 2025 * | -6M | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-1.77
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.67% |
Latest transcript on BIOLASE, Inc.
1 day | +1.51% | ||
1 week | +4.60% | ||
Current month | +13.35% | ||
1 month | +13.58% | ||
3 months | +13.20% | ||
6 months | -85.51% | ||
Current year | -85.02% |
Managers | Title | Age | Since |
---|---|---|---|
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director of Finance/CFO | 53 | 21-01-31 | |
Steven Sandor
COO | Chief Operating Officer | 44 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Lord
CHM | Chairman | 69 | 14-07-31 |
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director/Board Member | 73 | 21-08-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.1681 | +1.51% | 927,066 |
24-05-24 | 0.1656 | +0.67% | 1,966,852 |
24-05-23 | 0.1645 | -14.32% | 3,495,336 |
24-05-22 | 0.192 | +20.38% | 6,297,345 |
24-05-21 | 0.1595 | -0.75% | 2,415,279 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.02% | 5.53M | |
+7.87% | 223B | |
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B |
- Stock Market
- Equities
- BIOL Stock